Centanni S - Search Results

1

Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease.

Santus P, Sola A, Carlucci P, Fumagalli F, Di Gennaro A, Mondoni M, Carnini C, Centanni S, Sala A. Santus P, et al. Among authors: centanni s. Am J Respir Crit Care Med. 2005 Apr 15;171(8):838-43. doi: 10.1164/rccm.200404-558OC. Epub 2004 Dec 3. Am J Respir Crit Care Med. 2005. PMID: 15579728 Clinical Trial.

2

Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthma.

Centanni S, Carlucci P, Santus P, Boveri B, Tarricone D, Fiorentini C, Lombardi F, Cazzola M. Centanni S, et al. Respiration. 2000;67(1):60-4. doi: 10.1159/000029464. Respiration. 2000. PMID: 10705264

3

Psychological issues in the treatment of asthmatic patients.

Centanni S, Di Marco F, Castagna F, Boveri B, Casanova F, Piazzini A. Centanni S, et al. Respir Med. 2000 Aug;94(8):742-9. doi: 10.1053/rmed.1999.0766. Respir Med. 2000. PMID: 10955748 Free article.

4

Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.

Cazzola M, Boveri B, Carlucci P, Santus P, DiMarco F, Centanni S, Allegra L. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 2000;13(6):301-5. doi: 10.1006/pupt.2000.0258. Pulm Pharmacol Ther. 2000. PMID: 11061985 Clinical Trial.

5

Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.

Centanni S, Santus P, Casanova F, Di Marco F, Brazzola G, Canonica GW. Centanni S, et al. Drugs Exp Clin Res. 2000;26(4):133-8. Drugs Exp Clin Res. 2000. PMID: 11109513

6

Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.

Cazzola M, Centanni S, Regorda C, di Marco F, di Perna F, Carlucci P, Boveri B, Santus P. Cazzola M, et al. Among authors: centanni s. Pulm Pharmacol Ther. 2001;14(1):41-5. doi: 10.1006/pupt.2000.0267. Pulm Pharmacol Ther. 2001. PMID: 11162418 Clinical Trial.

7

The potential role of tocopherol in asthma and allergies: modification of the leukotriene pathway.

Centanni S, Santus P, Di Marco F, Fumagalli F, Zarini S, Sala A. Centanni S, et al. BioDrugs. 2001;15(2):81-6. doi: 10.2165/00063030-200115020-00002. BioDrugs. 2001. PMID: 11437677 Review.

8

Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.

Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L. Cazzola M, et al. Among authors: centanni s. Respiration. 2001;68(5):452-9. doi: 10.1159/000050550. Respiration. 2001. PMID: 11694805 Clinical Trial.

9

Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollution.

Centanni S, Di Marco F, Castagna F, Santus P, Guarnieri R, Allegra L. Centanni S, et al. Monaldi Arch Chest Dis. 2001 Aug;56(4):304-8. Monaldi Arch Chest Dis. 2001. PMID: 11770209

10

Antileukotrienes in clinical development for asthma.

Centanni S, Santus P. Centanni S, et al. Expert Opin Investig Drugs. 2002 Jan;11(1):49-58. doi: 10.1517/13543784.11.1.49. Expert Opin Investig Drugs. 2002. PMID: 11772320 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters